Economic evaluation of Vacuum Assisted Closure® Therapy for the treatment of diabetic foot ulcers in France

International Wound Journal

Volumn 8, Issue 1, 2011, Pages 22-32

  Whitehead, Sarah J ^a   Forest Bendien, Véronique L ^b   Richard, Jean Louis ^c   Halimi, Serge ^d   Ha Van, Georges ^e   Trueman, Paul ^f  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Parktoren   (Netherlands)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e Service de Neurorééducation   (France)

^f BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Cost effectiveness; Diabetic foot ulcers; Negative pressure therapy; V.A.C. Therapy

Indexed keywords

ALGINIC ACID; ALGOSTERIL; UNCLASSIFIED DRUG; VALNOCTAMIDE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; FOOT AMPUTATION; FOOT ULCER; FRANCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; VACUUM; VACUUM ASSISTED CLOSURE; WOUND CARE;

AGED; COST-BENEFIT ANALYSIS; DIABETIC FOOT; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; NEGATIVE-PRESSURE WOUND THERAPY; TREATMENT OUTCOME;

EID: 78751692451     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2010.00739.x     Document Type: Article

References (42)

1. Markowitz JS, Gutterman EM, Magee G, Margolis DJ. Risk of amputation in patients with diabetic foot ulcers: a claims-based study. Wound Repair Regen 2006;14:11-7.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
3. Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Diabete traité en France 2007: un taux de prévalence proche de 4% et des disparités géographiques croissantes. Bull Epidémiol Hebd 2008;43:409-13.
4. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM, Wukich DK, Andersen C, Vanore JV; American College of Foot and Ankle Surgeons. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg 2006;45:S1-66.
5. Boulton AJ, Vileikyte L, Ragnarson Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366:1719-24.
6. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7.
7. Apelqvist J, Armstrong DG, Lavery LA, Boulton AJM. Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds. Am J Surg 2008;195:782-8.
8. Ragnarson Tennvall G, Apelqvist J. Health related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 2000;14:235-41.
9. Banwell P. V.A.C. Therapy clinical guidelines: a reference source for clinicians (International). Produced by Medical Education Partnership (MEP) Ltd on behalf of KCI Europe Holding BV. London, 2007. ISBN 978-90-78026-01-3.
10. Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers. Diabetes Care 2008;31:631-6.
11. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005;366:1704-10.
12. McCallon SK, Knight CA, Valiulus JP, Cunningham MW, McCulloch JM, Farinas LP. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage 2000;46:28-34.
13. Philbeck T, Schroeder W, Whittington KT. Vacuum-assisted closure therapy for diabetic foot ulcers: clinical and cost analyses. Home Health Care Consultant 2001;8:27-32.
14. Schwien T, Gilbert J, Lang C. Pressure ulcer prevalence and the role of negative pressure wound therapy in home health quality outcomes. Ostomy Wound Manage 2005;51:47-60.
15. Frykberg RG, Williams DV. Negative-pressure wound therapy and diabetic foot amputations: a retrospective study of payer claims data. J Am Podiatr Med Assoc 2007;97:351-9.
16. Kaplan M. Negative pressure wound therapy in the management of abdominal compartment syndrome. Ostomy Wound Manage 2004;50(11A Suppl):20S-25S.
17. Niezgoda JA. The economic value of negative pressure wound therapy. Ostomy Wound Manage 2005;51(2A Suppl):44S-47S.
18. Kaplan M, Daly D, Stemkowski S. Early intervention of negative pressure wound therapy using Vacuum-Assisted Closure in trauma patients: impact on hospital length of stay and cost. Adv Skin Wound Care 2009;22:128-32.
19. De Leon JM, Barnes S, Nagel M, Fudge M, Lucius A, Garcia B. Cost-effectiveness of negative pressure wound therapy for postsurgical patients in long-term acute care. Adv Skin Wound Care 2009;22:122-7.
20. Flack S, Apelqvist J, Keith M, Trueman P, Williams D. An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers. J Wound Care 2008;17:71-8.
21. Le Franc B, Sellal O, Grimandi G, Duteille F. Cost-effectiveness analysis of vacuum-assisted closure in the surgical wound bed preparation of soft tissue injuries. Ann Chir Plast Esthet 2010;55: 195-203.
22. Lavery LA, Boulton AJ, Niezgoda JA, Sheehan P. A comparison of diabetic foot ulcer outcomes using negative pressure wound therapy versus historical standard of care. Int Wound J 2007;4:103-13.
23. Apelqvist J, Ragnarson Tennvall G, Larrson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 1995;16:388-94.
24. Persson J, Willis M, Odegaard K, Apelqvist J. The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranax): a core model with an application using Swedish cost data. Value Health 2000;3:39-46.
25. Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2006.
26. Ragnarson Tennvall G, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 2000;18:225-38.
27. Apligraf Medicare product and related procedure reimbursement. [database on the Internet] 2006 [accessed on 27 July 2006].
28. Redekop WK, Stolk EA, Kok E, Lovas K, Kalo Z, Busschbach JJ. Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments. Diabetes Metab 2004;30:549-56.
29. Assurance Maladie en Ligne. Liste des Produits et Prestations Remboursables [database on the Internet] 2009. Version from 24 March. Available at:
30. Assurance Maladie en Ligne. Classification Commune des Actes Médicaux. [database on the Internet] 2009. Available at:
31. AMeli. Assurance Maladie en Ligne. Table Nationale de codage de Biologie. 2009.
32. Agence Technique de Information sur Hospitalisation. Echelle nationale de coûts. Echelle et coûts décomposés 2003-2004 [database on the Internet] 2007. Available at:
33. Chambaud L, Khennouf M, Lannelongue C, Mordelet P, Dusehu E, Geffroy L. Enquête sur la rémunération des médecins et chirurgiens hospitaliers. Inspection générale des affaires sociales 2009.
34. Infirmiers.com. La communauté infirmière. Comment lire votre fiche de paye? 2009.
35. Editions du Vidal. Le dictionnaire Vidal 2008. 84th ed. 2008. UBM Medica. ISBN 978-2-85091-169-9
36. Assurance Maladie en Ligne. Liste des groupes génériques soumis au TFR (actualisée au 1er mars 2009) [database on the Internet] 2009.
37. Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, Van Baal J, Van Merode F, Schaper N. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med 2008;25:700-7.
38. Richard J, Parer-Richard C. Le pied diabétique: données épidémiologiques et économiques. In: Richard JL, Vannereau D, editors. Le pied diabétique. Paris: Editions MF, 2002:23-43.
39. Ubbink DT, Westerbos SJ, Nelson EA, Vermeulen H. A systematic review of topical negative pressure therapy for acute and chronic wounds. Br J Surg 2008;95:685-92.
40. Hunter JE, Teot L, Horch R, Banwell PE. Evidence-based medicine: vacuum-assisted closure in wound care management. Int Wound J 2007;4:256-69.
41. European Wound Management Association (EWMA). Position Document: Topical negative pressure in wound management. London: MEP Ltd, 2007.
42. World Union of Wound Healing Societies (WUWHS). Principles of best practice: vacuum assisted closure: recommendations for use. A concensus document. London: MEP Ltd, 2008.